Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
The Joint Science and Technology Office (JSTO) Science Review (JSR) fosters collaboration, cooperation and innovation by allowing program managers and senior leadership to understand the latest warfighter-driven technologies in development....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
DNA-based nucleic acid vaccines have the potential to become a universal platform solution to viral threat agents. The U.S. Department of Defense is currently developing DNA vaccines to protect against a variety of viral threats including alphaviruses, filoviruses and hantaviruses....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 04.26.2018
Often innovation is accomplished in incremental steps, rather than leaps and bounds. However, the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department recently deployed their Empowering the Development of Genomics Expertise (EDGE) Bioinformatics tool, which has the ability to rapidly revolutionize how genomics are used to safeguard warfighters....
